mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.6 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |